Revisiting comorbidities in gout: a cluster analysis

Pascal Richette1, Pierre Clerson2, Laure Périssin3

  • 1Université Paris 7, UFR médicale, Assistance Publique-Hôpitaux de Paris, Hôpital Lariboisière, Fédération de Rhumatologie, Paris, Cedex 10, France.

Insights

Cluster analysis identified five distinct patient groups based on comorbidities in gout. These phenotypes may indicate different underlying disease processes, aiding personalized gout management.

Area of Science:

  • Rheumatology
  • Internal Medicine
  • Epidemiology

Background:

  • Gout is frequently associated with numerous comorbidities, complicating patient management.
  • The relationship between gout and its comorbidities is complex and not fully understood.
  • Identifying distinct patient subgroups based on comorbidities can improve understanding of gout's pathophysiology.

Purpose of the Study:

  • To identify distinct clinical phenotypes of gout based on comorbid conditions using cluster analysis.
  • To explore the heterogeneity within a large cohort of patients diagnosed with gout.

Main Methods:

  • A cross-sectional multicentre study involving 2763 patients with gout.
  • Cluster analysis was performed on variables and observations to identify homogeneous patient subgroups.
  • Key comorbidities analyzed included hypertension, obesity, diabetes, dyslipidaemia, heart failure, coronary heart disease, renal failure, liver disorders, and cancer.

Main Results:

  • Five distinct clusters of gout patients were identified based on their comorbidity profiles.
  • Cluster C1 (12%) had isolated gout with few comorbidities.
  • Cluster C2 (17%) featured obesity and hypertension; C3 (24%) had high rates of type 2 diabetes; C4 (28%) presented with dyslipidaemia; C5 (18%) showed high prevalence of cardiovascular disease and renal failure.

Conclusions:

  • Cluster analysis successfully differentiated gout patients into five distinct phenotypes.
  • These identified phenotypes may represent different pathophysiological pathways in gout.
  • This phenotyping approach could inform more targeted treatment strategies for gout patients.
Abstract

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.9K
Factors Affecting Illness01:18

Factors Affecting Illness

When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
5.4K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
572
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
869
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
773